Does lithium have a role in the prevention and management of clozapine-induced granulocytopenia?

Psychiatric Annals

Volumn 29, Issue 10, 1999, Pages 597-603

  Oyewumi, L Kola ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b Brock V ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033467463     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19991001-09     Document Type: Article

References (40)

1. Meltzer H. Highlights: Treatment-Resistant Schizophrenia and Beyond. Current Concepts and future Prospects. London: Novartis Pharma AG; 1998:1.
2. Coward DM. General pharmacology of clozapine. Br J Psychiatry. 1992;160(suppl 17)5-11.
3. Lieberman JA, Kane JM, Johns CA. Clozapine: guidelines for clinical management. J Clin Psychiatry. 1989b;50:329-338.
4. Jefferson JW, Greist JH. Lithium therapy. In: Comprehensive Text Book of Psychiatry, 5th ed. Baltimore: Williams and Wilkins; 1989:1655.
5. Gallichio VS, Hughs NK. Lithium stimulation of hematopoiesis: demonstration that lithium influences the spatial distribution of hematopoietic progenitor cells within endosteal bone marrow. Lithium. 1992;3:117-124.
6. Pisciotta AV. Drug-induced agranulocytosis: peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. Blood Rev. 1990;4:226-237.
7. Gerson SL, Meltzer H. Mechanisms of clozapine-induced agranulocytosis. Drug Safety. 1992;7(suppl 1):17-25.
8. Krupp P, Barnes P. Clozapine-associated agranulocytosis: risk and aetiology. Br J Psychiatry. 1992;160(suppl 17):5-11.
9. Lieberman JA, Alvir JM. A report of clozapine-induced agranulocytosis in the United States. Drug Safety. 1992;7(suppl 1):1-2.
10. Honigfeld G. The clozapine national registry system: forty years of risk management. J Clin Psychiatry. 1996;14:29-32.
11. Sandoz Inc. Clozaril (Clozapine): The Atypical Antipsychotic. East Hanover, NJ: Sandoz Pharmaceuticals Corp.; 1990.
12. Panteleeva GP, Tsutsul Kovskaya MY, Belyaer BS, et al. Clozapine in the treatment of schizophrenic patients: an international multicentre trial. Clin Ther. 1987;10:57-68.
13. Murphy DL, Goodwin FK, Bunney WE. Leukocytosis during lithium treatment. Am J Psychiatry. 1971;127:1559-1561.
14. Tisman G, Herbert V, Rosenblast S. Evidence that lithium induces human granulocyte proliferation: elevated serum vitamin B12 binding capacity in vivo and granulocyte colony proliferation in vitro. Br J Haematol. 1973;24:767-771.
15. Shopsin B, Friedmann R, Gershon S. Lithium and leukocytosis. Clin Pharmacol Ther. 1971;12:923-928.
16. Stein RS, Howard CA, Brennan M, et al. Lithium carbonate and granulocyte production: dose optimization. Cancer. 1981;48:2697-2701.
17. Boggs DR, Joyce RA. The hematopoietic effects of lithium. Semin Hematol. 1983;20:129-138.
18. Barr RD. The role of the lymphocyte in haemopoiesis. Scott Med J. 1979;24:267-272.
19. Fernandez LA, Fox RA. Perturbation of human immune system by lithium. Clin Exp Immunol. 1980;41:527-532.
20. Chan HSL, Saunders EF, Freedman MH. Modulation of human haematopoiesis by prostaglandin and lithium. J Lab Clin Med. 1980;95:125-304.
21. Lyman GH, Williams CG, Preston D, et al. Lithium carbonate in patients with small cell lung cancer receiving combination chemotherapy and radiotherapy. Am J Med. 1981;70:1222-1229.
22. Stein RS, Beaman C, Ali MY, Hansen R, Jenkins DD, Jumez HG. Lithium carbonate attenuation of chemotherapy induced neutropenia. N Engl J Med. 1977;297:430-431.
23. Steinherz PG, Rosen G, Ghavimi F, et al. The effect of lithium carbonate on leukemia after chemotherapy. J Pediatr. 1980;6:923-927.
24. Yassa R, Ananth J. Treatment of neuroleptic induced leukopenia with lithium carbonate. Can J Psychiatry. 1981;26:487-489.
25. Yassa R, Nair V. Long term lithium treatment of psychotropic-induced leukopenia. Am J Psychiatry. 1981; 138:1392.
26. Gallichio VS, Hulette BC. In vitro effect of lithium on carbamazepine induced inhibition of murine and human bone marrow derived granulocyte-macrophase, erythroid and megakaryocyte progenitor stem cells. Proc Soc Exp Biol Med. 1989;190:109-116.
27. Servant D, Danel T, Goudeman M. Lithium therapy in carbamazepine-induced agranulocytosis. Am J Psychiatry. 1988;145:381.
28. Kramlinger KG, Post RM. Addition of lithium carbonate to carbamazepine: haematological and thyroid effects. Am J Psychiatry. 1990;147:615-620.
29. Lyman GH, William CC, Preston D. The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy. N Engl J Med. 1980;302:257-260.
30. Ananth J, Johnson KM. Lithium and granulopoiesis: practical applications. Lithium. 1993;4:13-23.
31. Gershon SL, Lieberman JA, Friedenberg WR, Lee D, Marx JJ Jr, Meltzer H. Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet. 1991;338:262-263.
32. Valevski A, Modai I, Lahav M, Weizman A. Clozapine-lithium combined treatment and agranulocytosis. Int Clin Psychopharmacol. 1993;8:63-65.
33. Silverstone PH. Prevention of clozapine-induced neutropenia by pretreatment with lithium. J Clin Psychopharmacol. 1998;18:86-89.
34. Adityanjee. Modification of clozapine-induced leukopenia and neutropenia with lithium carbonate. Am J Psychiatry. 1995;152:648-649.
35. Oyewumi LK. Efficacy of lithium in treating severe clozapine-induced leukopenia and neutropenia. Presented at the 21st Annual Meeting of the Canadian College of Neuropsychopharmacology; June 1998.
36. Garcia G, Crismon ML, Dorson PG. Seizures in two patients after addition of lithium to a clozapine regimen. J Clin Psychopharmacol. 1994;14:426-428.
37. Pope HG, Cole JO, Choras TP, Fuliviler CE. Apparent neuroleptic malignant syndrome with clozapine and lithium. J Nerv Ment Dis. 1986;174:493-495.
38. Thornberg SA, Ereshefsky L. Neuroleptic malignant syndrome associated with clozapine monotherapy. Pharmacotherapy. 1993;13:510-514.
39. Weller M, Kornhuber J. Clozapine rechallenge after an episode of neuroleptic malignant syndrome. Br J Psychiatry. 1992;161:855-856.
40. Morley DC Jr, Galbraith PR. Effect of lithium on granulopoiesis in culture. Can Med Assoc J. 1978;118:288-290.